Prevalence of systemic immunoreactivity to Aggregatibacter actinomycetemcomitans leukotoxin in relation to the incidence of myocardial infarction
2011

Link Between Oral Bacteria and Heart Attacks

Sample size: 1532 publication 10 minutes Evidence: moderate

Author Information

Author(s): Anders Johansson, Marie Eriksson, Ann-Marie Åhrén, Kurt Boman, Jan-Håkan Jansson, Göran Hallmans, Ingegerd Johansson

Primary Institution: Umeå University

Hypothesis

Does systemic immunoreactivity to Aggregatibacter actinomycetemcomitans leukotoxin affect the incidence of myocardial infarction?

Conclusion

The study found a high prevalence of systemic immunoreactivity to A. actinomycetemcomitans leukotoxin, but it does not decrease the risk for myocardial infarction.

Supporting Evidence

  • 53.3% of plasma samples could neutralize A. actinomycetemcomitans leukotoxin.
  • Women with low neutralizing capacity had a higher incidence of myocardial infarction.
  • The study population included 1,532 participants with matched cases and controls.

Takeaway

This study looked at whether a certain bacteria in the mouth could help protect against heart attacks, but it turns out it doesn't.

Methodology

The study analyzed plasma samples for their ability to neutralize A. actinomycetemcomitans leukotoxin using a bioassay.

Potential Biases

Potential for type-1 error in the significant association found for women.

Limitations

The periodontal status of participants was not known, which could affect the results.

Participant Demographics

Participants were aged 30-77 years, with 532 cases of myocardial infarction and 1,000 matched controls.

Statistical Information

P-Value

<0.001

Confidence Interval

1.13-2.8

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-11-55

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication